240
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The treatment patterns of castration-resistant prostate cancer in Japan, including symptomatic skeletal events and associated treatment and healthcare resource use

, , , , &
Pages 511-517 | Received 18 Jan 2017, Accepted 24 Feb 2017, Published online: 10 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ann Colosia, Annete Njue, Zahid Bajwa, Erika Dragon, Rebecca L Robinson, Kristin M Sheffield, Sheena Thakkar & Steven H Richiemer. (2022) The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review. Journal of Pain Research 15, pages 3399-3412.
Read now
Anuj Shah, Ruchit Shah, Nehemiah Kebede, Ateesha Mohamed, Marc Botteman, Reg Waldeck & Arif Hussain. (2020) Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy. Journal of Medical Economics 23:4, pages 330-346.
Read now

Articles from other publishers (3)

Andrea Leith, Jeri Kim, Amanda Ribbands, Emily Clayton, Lingfeng Yang & Sameer R. Ghate. (2022) Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan. Advances in Therapy 39:5, pages 2236-2255.
Crossref
Fabrizio Fontana, Monica Marzagalli, Marina Montagnani Marelli, Michela Raimondi, Roberta Moretti & Patrizia Limonta. (2020) Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions. International Journal of Molecular Sciences 21:24, pages 9511.
Crossref
Ruchitbhai Shah, Marc Botteman & Reginald Waldeck. (2019) Treatment characteristics for nonmetastatic castration-resistant prostate cancer in the United States, Europe and Japan. Future Oncology 15:35, pages 4069-4081.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.